Pharmaceutical Supply – Sumatriptan Succinate Tablets

The Defense Logistics Agency, under the Department of Defense, has contracted for the procurement and delivery of one unit of Sumatriptan Succinate Tablets, identified by NSN 6505017278704, for use in migraine treatment aboard a U.S. Navy vessel. The delivery is to be made FOB destination, meaning the supplier assumes all costs and risks until the medication reaches its final destination on the vessel. The contract falls under NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, indicating the product is domestically produced in compliance with federal pharmaceutical standards. Submitted as a subcontract, the transaction is part of a broader defense procurement effort, with the solicitation posted on June 25, 2026, and linked to the DIBBS system under award number SPE2DX25D8022 and delivery order SPE2D926F6840. No set-aside provisions or specific point of contact information is provided, and the exact place of performance is not detailed beyond the requirement to deliver to a U.S. Navy vessel.